Investor Relations

Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery.

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management

2.8 MB

Wednesday, October 16, 2024

11:00am EDT

Innovating beyond boundaries for patients

Krista Fogarty phone: (801) 994-7383 email: kf@lipocine.com